Loading…

Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea

Active glycemic control has been proven to delay the onset and slow the progression of diabetic retinopathy, nephropathy, and neuropathy in diabetic patients, but the optimal level is obscure in end-stage renal disease. In this study, we evaluated the effect of hemoglobin A1c (HbA1c) on mortality of...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2015-08, Vol.10 (8), p.e0136085-e0136085
Main Authors: Park, Ji In, Bae, Eunjin, Kim, Yong-Lim, Kang, Shin-Wook, Yang, Chul Woo, Kim, Nam-Ho, Lee, Jung Pyo, Kim, Dong Ki, Joo, Kwon Wook, Kim, Yon Su, Lee, Hajeong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Active glycemic control has been proven to delay the onset and slow the progression of diabetic retinopathy, nephropathy, and neuropathy in diabetic patients, but the optimal level is obscure in end-stage renal disease. In this study, we evaluated the effect of hemoglobin A1c (HbA1c) on mortality of diabetic patients on dialysis, focusing on age and dialysis type. Of 3,302 patients enrolled in the prospective cohort for end-stage renal disease in Korea between August 2008 and October 2013, 1,239 diabetic patients who had been diagnosed with diabetes or having HbA1c≥6.5% at the time of enrollment were analyzed. Age was categorized as
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0136085